Levelfox-OZ Oral Suspension is a combination antibiotic formulation containing Levofloxacin 50mg and Ornidazole 125mg per dose, designed for the treatment of mixed bacterial and protozoal infections. Levofloxacin, a fluoroquinolone antibiotic, exhibits broad-spectrum activity by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and transcription. Ornidazole, a nitroimidazole derivative, is effective against anaerobic bacteria and protozoa by causing DNA strand breakage and inhibiting nucleic acid synthesis. This synergistic combination is indicated for infections involving susceptible aerobic and anaerobic pathogens, including gastrointestinal infections, intra-abdominal infections, pelvic inflammatory disease, and certain respiratory tract infections. Levelfox-OZ Oral Suspension is particularly useful in cases where mixed infections are suspected or confirmed. The oral suspension formulation facilitates ease of administration, especially in pediatric and geriatric populations or patients with swallowing difficulties. Dosage and duration should be determined by a healthcare professional based on the severity and type of infection, renal function, and patient-specific factors. Caution is advised in patients with a history of hypersensitivity to fluoroquinolones or nitroimidazoles, and potential side effects include gastrointestinal disturbances, CNS effects, and hypersensitivity reactions. Monitoring for adverse effects and therapeutic response is recommended during treatment.